ArticleOncology reports2020

Selective inhibition of PI3K110α as a novel therapeutic strategy for cetuximab‑resistant oral squamous cell carcinoma.

Hiroki Tsuchihashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.